Viking Global Investors LP Bridge Bio Pharma, Inc. Transaction History
Viking Global Investors LP
- $35.2 Billion
- Q3 2025
A detailed history of Viking Global Investors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 15,977,849 shares of BBIO stock, worth $1.06 Billion. This represents 2.36% of its overall portfolio holdings.
Number of Shares
15,977,849
Previous 18,555,375
13.89%
Holding current value
$1.06 Billion
Previous $801 Million
3.58%
% of portfolio
2.36%
Previous 2.54%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
446Shares Held
184MCall Options Held
11.3MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$880 Million27.71% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$826 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X08.74MShares$580 Million0.22% of portfolio
-
Farallon Capital Management LLC San Francisco, CA8.19MShares$544 Million1.84% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...